ENSC Stock Analysis: Buy, Sell, or Hold?
ENSC - Ensysce Biosciences, Inc. Common Stock
$0.24
-0.01 (-3.78%)
▼
5d:
-7.77%
30d:
-36.02%
90d:
-46.67%
HOLD
LOW Confidence
Analysis Updated: Jun 9, 2026 12:00 AM ET
Earnings: May 19, 2026
0d
Get Alerted When ENSC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENSC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ENSC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ENSC is currently trading at $0.24, which is considered oversold relative to its 30-day fair value range of $0.27 to $0.36.
Technical Outlook: Technically, ENSC is in a strong downtrend. Immediate support is located at $0.24, while resistance sits at $0.31. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.45 (+6376.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENSC is in a strong downtrend. Immediate support is located at $0.24, while resistance sits at $0.31. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.45 (+6376.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.27 -
$0.36
Company Quality Score
51/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 6376.4% below Wall St target ($16.45)
- CAUTION: Recommendation downgraded due to -7.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.27 -
$0.36
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.24
Resistance Level
$0.31
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.31
Wall Street Target
$16.45
(+6376.4%)
Revenue Growth (YoY)
-27.2%
Profit Margin
-250.4%
Share & Embed Analysis
Last updated: June 10, 2026 12:23 PM ET
Data refreshes hourly during market hours. Next update: 1:23 PM
Data refreshes hourly during market hours. Next update: 1:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENSC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 53 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 53 HOLD |
